Abstract:their therapeutic potential in CLC has not been determined.Here, we identified that miR-410 is involved in CLC development through direct regulation of the X-linked inhibitor of apoptosis (XIAP).Methods: A microRNA library (810 microRNAs) was transfected in TFK CLC cells and cell viability was measured 48h later by a CellTiter-Glo assay.MicroRNA array analysis was performed in 22 human CLCs and 12 normal human cholangiocytes MiR-410 was overexpressed (20nM) in TFK cells and soft-agar colony and matrigel invasion assays were performed.MiR-410 was overexpressed in TFK CLC cells or suppressed (20nM) in H69 non-malignant cholangiocytes and their ability to form colonies in soft-agar was tested 20 days later.5x106 TFK cells were injected subcutaneously in nude mice and when tumors reached 100mm3 size, the mice were randomly distributed in groups: untreated, treated with miR-410 (2mg/kg), treated with sorafenib (20mg/kg), treated with miR-410 and sorafenib.All treatments were repeated for 4 cycles every 5 days and tumor size was measured in a daily basis.Results: The microRNA screen revealed that miR-410 suppressed effectively (72%) the growth of TFK cholangiocarcinoma cells.Furthermore, microRNA array analysis in 22 human cholangiocarcinomas and 12 normal human cholangiocytes revealed that miR-410 was highly (9.1-fold) down-regulated in CLCs relative to normal cholangiocytes.Overexpression of miR-410 suppressed (82%) the colony formation ability and invasiveness (6.6-fold) of TFK cells.On the other hand, inhibition of miR-410, by an antisense-microRNA against miR-410, transformed H69 non-malignant cholangiocytes.Bioinformatic analysis revealed that miR-410 has a binding site in the 3'UTR of XIAP gene.MiR-410 overexpression inhibited 72% XIAP luciferase activity and 7.1-fold XIAP mRNA levels in TFK cells.MiR-410 was found down-regulated and XIAP was found up-regulated in 12/22 (54.5%) human CLCs suggesting their human relevance.Overexpression of miR-410 suppressed 64% while sorafenib suppressed 38% the growth of TFK xenograft tumors in mice.Combinatorial treatment with miR-410 and sorafenib suppressed more effectively (88%) TFK tumor growth.Conclusion: We have identified that the miR-410/XIAP pathway is important for the transformation of human cholangiocytes and miR-410 treatment as a monotherapy or in combination with sorafenib suppresses CLC tumor growth in mice, suggesting its therapeutic potential for CLC patients.1050

Paulinia cupana (Guarana) for the treatment of cancer-related fatigue in patients undergoing radiation therapy or chemotherapy: A meta-analysis of three clinical trials.

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

Inhibition of RIPK 1 expression and facilitation of TRAIL-induced hepatocellular carcinoma cell apoptosis by miR-141

Microrna-26 a Induces a Mitochondrial Apoptosis Mediated by P 53 Through Targeting to Inhibit Mcl 1 in Human Hepatocellular Carcinoma

Mcl-1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells

mir-29 regulates Mcl-1 protein expression and apoptosis

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance

Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p

Suppression of miR-21-3p enhances TRAIL-mediated apoptosis in liver cancer stem cells by suppressing the PI3K/Akt/Bad cascade via regulating PTEN

Downregulation of SNAIL Sensitizes Hepatocellular Carcinoma Cells to TRAIL-induced Apoptosis by Regulating the NF-κB Pathway.

Mir-135A/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1

microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma

1052 MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer Cells by Downregulating Oncogene BMI1

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Down-regulation of miR-26 a-5 p and its regulatory roles in hepatocellular carcinoma : an in silico analysis

MicroRNA-506 Inhibits the Proliferation and Invasion of Mantle Cell Lymphoma Cells by Targeting B7H3.

The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells

Knockdown of Mir-25 Increases the Sensitivity of Liver Cancer Stem Cells to TRAIL-induced Apoptosis Via PTEN/PI3K/Akt/Bad Signaling Pathway